Novel Injection Nearly Halved Proteinuria in IgA Nephropathy

By News Health
2 weeks Ago

(MedPage Today) — HOUSTON — A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients with IgA nephropathy, interim findings from the phase III ORIGIN 3 trial found.
Among 203 participants…

Source link : https://www.medpagetoday.com/meetingcoverage/asn/118350

Author :

Publish date : 2025-11-06 20:15:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Can Anticoagulants Cut Stroke Risk in Seniors With AF?

Cognition Improved With Some Drugs for Depression

Why Do Caregivers Delay Early Allergenic Food Introduction?

Which Burnout Programs Work Best for Health Professionals?

‘Lean Diabetes’ a Risk Factor for Dementia?

'California Sober' Trend Gets a Little Support From Trial